Understand the source comparison
GHRP-2 Acetate Price Comparison: Research-Grade Suppliers
Pricing transparency requires supplier-by-supplier comparison across identical specifications. The table below compares five supplier tiers for 5mg GHRP-2 Acetate vials at ≥98% purity, cataloguing what each price point includes and excludes. Budget (unverified
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Pricing transparency requires supplier-by-supplier comparison across identical specifications. The table below compares five supplier tiers for 5mg GHRP-2 Acetate vials at ≥98% purity, cataloguing what each price point includes and excludes.
- Budget (unverified)
- $42–$55
- None. Purity stated on label only
- No batch certificates
- Unspecified
- Lowest upfront cost, highest risk of molecular inconsistency. Acceptable only for preliminary feasibility testing where exact dosing is non-critical
- Mid-Tier (partial verification)
- $60–$75
- HPLC chromatogram provided on request
- Generic CoA without batch traceability
- Solid-phase (claimed, unverified)
- Functional for exploratory research but lacks MS confirmation of molecular weight. Deletion sequences or impurities may go undetected
- Verified Research-Grade
- $75–$95
- HPLC + MS reports included with every batch
- Full batch-specific CoA with endotoxin results
- Verified SPPS with ≥98% purity
- Standard for peer-reviewed research. Includes molecular weight confirmation, sequence verification, and contaminant screening
- Premium Research-Grade
- $95–$120
- HPLC + MS + NMR + sterility testing
- Comprehensive analytical package with raw data files
- SPPS with ≥99% purity target
- Required for GLP-compliant studies or publications in high-impact journals. Eliminates nearly all synthesis-related variability
- Institutional Contract
- $65–$85 (volume discount applied)
- Same as Verified tier
- Batch-specific CoA
- SPPS ≥98%
- Best per-unit economics for labs conducting multi-month protocols. Pricing scales with commitment volume
- The 'Professional Assessment' column clarifies use cases. For preliminary feasibility studies evaluating whether GHRP-2 influences a particular biomarker in a model system, budget-tier peptides suffice. For dose-response curves intended for publication, verified research-grade is the floor. For regulatory submissions or multi-site trials, premium-grade material with NMR confirmation becomes necessary.